TB Research

Treatment of tuberculosis

Jean-Pierre Zellweger

˜The œbiomedical & life sciences collection. · 2021-09

Abstract

Tuberculosis is still one of the main infectious diseases affecting mankind and is poorly controlled, despite the availability of cheap and effective drugs for the past 40–50 years. There are three basic principles of treatment against tuberculosis defined by the WHO and International Union Against Tuberculosis and Lung Disease (IUATLD). First is the use of potent bactericidal drugs in combination, to render the patients noninfective as rapidly as possible and prevent the transmission to other patients. Second, prolonged treatment eradicates even the dormant bacteria and prevents relapse. Third, regular treatment with correct doses is given in order to prevent the development of drug resistance. Most cases of tuberculosis can still be cured by a correct combination of isoniazid, rifampicin, pyrazinamide and ethambutol administered for 2 months, followed by isoniazid and rifampicin for 4 months. Antituberculous drugs are associated with adverse events, particularly in patients with comorbidities such as HI...

MeSH terms

  • Pyrazinamide
  • Ethambutol
  • Rifampicin
  • Tuberculosis
  • Medicine
  • Isoniazid
  • Adverse effect
  • Drug
  • Antibiotics
  • Disease
  • Intensive care medicine
  • Pharmacology